Next Amgen CEO sees more markets, higher sales - Los Angeles Times

Next Amgen CEO sees more markets, higher sales Los Angeles present time Enbrel, the leading life drug for severe disease of the skin and rheumatoid arthritis, is Amgen's top seller, with 2010 sales of active $3.5 billion. Bradway aforementioned the company has gotten some crucial long-term contracts with clinics that manage its ... Summary Box: Amgen CEO sees higher sales in 2012 CBS News all 159 tidings articles » Link To Article